For millions of people living with type 1 diabetes (T1D), managing the condition is a relentless balancing act that requires continuous glucose monitoring, insulin delivery, and meticulous data tracking. The technologies that make this possible—insulin pumps, continuous glucose monitors (CGMs), and automated insulin delivery systems—have transformed care over the past two decades. Yet these life-saving tools come with two mounting problems: their high cost places them out of reach for many, and their disposable nature generates substantial medical waste. The Juvenile Diabetes Research Foundation (JDRF) has stepped forward as a leading force in tackling both challenges, pushing the frontiers of research, advocacy, and industry collaboration to make diabetes technologies sustainable and affordable for everyone.

JDRF's vision is not simply about cheaper devices or greener production. It is about fundamentally rethinking how diabetes care is delivered and financed, ensuring that innovation serves equity and environmental stewardship alongside clinical excellence. By funding breakthrough research, influencing policy, and educating communities, JDRF is driving a future where T1D management is effective, accessible, and kind to the planet.

The Sustainability Challenge in Diabetes Care

Diabetes devices are among the most waste-intensive medical technologies in daily use. A single CGM sensor is often discarded every 7 to 14 days, along with plastic applicators, adhesive patches, and protective packaging. Insulin pump infusion sets are replaced every 2 to 3 days, generating more plastic and adhesive waste. Test strips, lancets, and batteries add to the environmental load. According to a 2022 report, the global diabetes device market produces an estimated 5,000 tons of non‑biodegradable waste annually, much of which ends up in landfills or incinerators.

Beyond physical waste, the manufacturing and shipping of these devices consume significant energy and natural resources. Many components are made from petroleum‑based plastics that take centuries to decompose. The lithium‑ion batteries used in pumps and CGM transmitters also present toxic disposal issues. For the approximately 8.4 million people worldwide living with type 1 diabetes, the cumulative environmental footprint is substantial.

JDRF has recognized that sustainability must be embedded in the design and lifecycle of next‑generation devices. Instead of accepting disposability as a trade‑off for innovation, the foundation is actively funding research into reusable components, biodegradable materials, and closed‑loop systems that reduce the number of consumable parts. The goal is to break the cycle of "use and discard" without sacrificing accuracy, safety, or convenience.

Waste Reduction Through Smarter Design

One promising area JDRF is investing in is the development of longer‑lasting CGM sensors. Research teams are exploring enzyme‑free sensor technologies that could function for weeks or even months without replacement. Others are working on fully implantable sensors that require fewer external consumables. JDRF has also supported projects to create insulin pumps with refillable reservoirs and reusable infusion sets, dramatically cutting down on single‑use plastics.

In addition, JDRF encourages manufacturers to adopt more sustainable packaging—switching from individual blister packs to bulk dispensing, using recycled or compostable materials, and eliminating unnecessary cardboard and plastic. These efforts may seem incremental, but multiplied across millions of users worldwide, they can prevent tons of waste each year.

The Affordability Crisis in Type 1 Diabetes

Even as technology advances, the cost of diabetes care continues to skyrocket. In the United States, the average person with T1D spends over $6,000 per year on insulin and supplies alone. A single CGM sensor can cost $50–$100, and a new insulin pump runs $4,000–$6,000 before insurance. Out‑of‑pocket expenses for those without adequate coverage can reach hundreds of dollars per month, forcing some to ration insulin or reuse disposable equipment—practices that increase the risk of severe complications.

Globally, the picture is even starker. In low‑ and middle‑income countries, the price of a month’s supply of insulin can exceed a family’s income. Continuous glucose monitors and pumps are virtually inaccessible to the majority of the world’s 1.1 billion people who rely on some form of insulin. JDRF has made affordability a cornerstone of its mission, advocating for policies that lower device costs, expand insurance coverage, and incentivize the development of low‑cost alternatives.

Insurance and Policy Gaps

Even in high‑income countries, insurance coverage for new diabetes technologies is inconsistent. Many private insurers and public health programs impose strict criteria for CGM or pump access, such as proof of multiple daily injections failure or specific A1C thresholds. This delays adoption and leaves many people on older, less effective regimens. JDRF works with policymakers to remove these barriers, supporting legislation like the Medicare CGM Access Act and state‑level insulin copay caps. The foundation also pushes for international harmonization of device approvals to speed up access in underserved regions.

Another major affordability lever is bulk purchasing and pooled procurement. JDRF collaborates with non‑profit organizations and governments to negotiate lower prices for devices and insulin. For example, the foundation has partnered with the Clinton Health Access Initiative to reduce the cost of CGM sensors in Sub‑Saharan Africa. Such partnerships can slash prices by 30–50%, making technology viable for public health systems.

JDRF’s Strategic Initiatives to Drive Change

JDRF deploys a multi‑pronged strategy to accelerate both sustainability and affordability. Rather than hoping market forces alone will solve these problems, the foundation actively funds research, shapes policy, and incubates open‑source solutions.

Research Funding for Sustainable Innovation

Through its JDRF Research Portfolio, the foundation targets specific areas where advances in materials science, electronics, and engineering can yield more sustainable devices. One of its flagship programs, the Consortium for Advanced Diabetes Technology, brings together academics, startups, and industry veterans to tackle the full product lifecycle—from raw material sourcing to end‑of‑life recycling. Grants have supported the development of biodegradable sensor adhesives made from plant‑derived polymers, energy‑efficient wireless protocols that extend CGM battery life, and modular pump platforms that allow users to replace only worn components rather than the entire device.

JDRF also funds open‑source hardware projects that allow the diabetes community to modify and repair their own devices. The #WeAreNotWaiting movement has produced DIY artificial pancreas systems that use off‑the‑shelf components and free software. JDRF supports these efforts by providing legal guidance, clinical validation support, and funding for safety testing. By promoting open‑source designs, the foundation helps drive down costs and gives users greater control over their care.

Advocacy for Policy Change

JDRF’s advocacy team works relentlessly at the federal, state, and international levels. In the United States, the foundation has been instrumental in passing the Affordable Insulin Now Act and in securing coverage for CGM under Medicare Part B. Globally, JDRF is a founding member of the Global Alliance for the Prevention and Control of NCDs, lobbying the World Health Organization to include diabetes technology in essential medicines lists. These policy wins ensure that sustainable devices not only exist but are actually accessible to those who need them.

The foundation also pushes for value‑based pricing models, where manufacturers are reimbursed based on patient outcomes rather than per‑device sales. This aligns financial incentives with better, more durable technologies. For example, a company that produces a longer‑lasting CGM sensor would receive higher payments because it reduces overall waste and improves adherence. JDRF funds health economics studies that make the case for such models to insurers and payers.

Education and Community Empowerment

Sustainable and affordable technologies only help people if they know about them. JDRF runs educational campaigns that teach patients and healthcare providers how to choose and use devices that balance cost and environmental impact. The JDRF Sustainable Diabetes Care Toolkit offers practical tips on reducing waste, recycling device components, and integrating affordable alternatives into daily routines. The foundation also hosts virtual summits where users can share best practices for maintaining and repairing pumps and sensors, extending their usable lifespan.

On the advocacy front, JDRF empowers local chapters to lobby for insurance coverage and to partner with clinics to distribute donated devices. During the COVID‑19 pandemic, the foundation helped channel surplus CGM sensors and insulin to underserved communities, preventing equipment from being thrown away and simultaneously filling critical gaps in access.

Specific Technologies Poised to Transform Care

Several emerging technologies funded or supported by JDRF exemplify the convergence of sustainability and affordability. These are not theoretical—many are in clinical trials or early commercialization.

Biodegradable and Implantable Sensors

Researchers at the University of California, Santa Barbara, with JDRF support, have developed a fully biodegradable CGM sensor that dissolves harmlessly in the body after a month of use. Made from silk protein and enzymes, the sensor eliminates waste entirely. It transmits data wirelessly to a smartphone, and the only external component is a reusable receiver. The team is now working with JDRF to scale manufacturing and secure regulatory approval. Because the sensor uses inexpensive materials, it is projected to cost less than $20 per month—a fraction of current CGM expenses.

Retrofit Kits for Manual Insulin Pumps

Many people with T1D own older insulin pumps that lack CGM integration. JDRF funded OpenAPS, a project that developed a low‑cost chip called the RileyLink, which can be added to these pumps to create a closed‑loop system. For under $200—including a used smartphone—users gain automated insulin delivery. The chip connects to any CGM via Bluetooth and runs open‑source software. This approach extends the life of pumps that would otherwise be discarded and dramatically cuts the cost of advanced therapy.

Solar‑Powered CGM Transmitters

One of the most common wastes in diabetes is the transmitter battery that requires replacement every few months. JDRF has awarded grants to develop solar‑powered CGM transmitters that use thin‑film photovoltaic cells embedded in the device. These transmitters can last indefinitely, recharged by ambient light, and are fully recyclable at end of life. The first prototypes, tested in 2023, achieved accuracy equivalent to current market leaders. With JDRF’s support, the startup behind this technology is now seeking FDA clearance.

Global Impact and Future Directions

JDRF’s efforts are not limited to wealthy nations. The foundation is expanding its reach to low‑ and middle‑income countries where diabetes technology is virtually nonexistent. Partnerships with the World Health Organization and groups like Life for a Child are helping to design devices that can be manufactured locally, using renewable materials and simple supply chains. For instance, a JDRF‑backed project in India is adapting the biodegradable sensor design for mass production using local silk and bamboo components, reducing import costs and carbon footprint simultaneously.

Another frontier is artificial intelligence and data‑driven personalization. By using machine learning to optimize insulin delivery, JDRF believes it can reduce the amount of insulin and sensor supplies needed over time. Better‑controlled glucose levels mean fewer complications, fewer hospital visits, and less medical waste. The foundation is funding research into algorithms that adapt to individual physiology, potentially extending the life of sensor and pump components through more efficient usage patterns.

In the next decade, JDRF envisions a diabetes ecosystem where devices are modular, repairable, and essentially waste‑free. The goal is not only affordability and sustainability for today’s patients but also scalability for the growing number of people being diagnosed with type 1 diabetes worldwide. By aligning environmental and economic incentives, JDRF is demonstrating that responsible innovation is not only possible but profitable.

To learn more about JDRF's current initiatives, visit their official site: JDRF. For data on diabetes device waste, see this analysis from the World Health Organization. For an in‑depth look at open‑source diabetes technology, explore the OpenAPS community. Additional resources on sustainable medical device design can be found at the Nature Biotechnology journal.

Conclusion

The challenge of making diabetes technologies sustainable and affordable is immense, but JDRF is proving that concerted effort can move the needle. Through targeted research funding, policy advocacy, education, and partnerships, the foundation is reshaping the landscape of type 1 diabetes care. Every biodegradable sensor, every recycled pump component, and every policy that lowers out‑of‑pocket costs brings millions of people closer to a life where managing diabetes is no longer a financial and environmental burden. JDRF’s work is a powerful reminder that even the most advanced medical technology must serve the planet and the people who rely on it. A future in which sustainable and affordable diabetes care is the norm, not a privilege, is now within reach—and JDRF is leading the way.